Specific and Sensitive Immunological Diagnosis of Chagas' Disease by Competitive Antibody Enzyme Immunoassay Using a Trypanosoma cruzi-Specific Monoclonal Antibody

View More View Less
  • * Centre d'Immunologie et de Biologie Parasitaire, Institut Pasteur, 15 rue Camille Guérin, 59019 Lille Cédex, France
  • ** Instituto Boliviano de Biologia de Altura, La Paz, Bolivia
  • Laboratoire de Parasitologie, Faculté de Médecine, ULB, Bruxelles, Belgium
  • Centro de Investigaciones Sobre Endemias Nacionales, Santa Fe, Argentina
  • § Nucleo de Medicina Tropical, Fortaleza, Brazil
  • Institut de Médecine Tropicale, Anvers, Belgium

Coexistence of Chagas' disease with leishmaniasis and T. rangeli infection in endemic areas and cross-reactivity between corresponding etiological agents can confuse the immunodiagnosis of Chagas' disease. A discriminative serological test could therefore represent a major advance in specific immunodiagnosis. A competitive antibody enzyme immunoassay against a component 5-enriched preparation, using a T. cruzi species-specific monoclonal antibody has allowed development of a specific serodiagnosis of Chagas' disease with high sensitivity (96.6% in undetermined and chronic phases of infection). This test can differentiate Chagas' disease from other cross-reacting parasitic diseases in areas where concomitant infections are unknown or suspected.